Paper3277680
Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha.
Hehlmann R and 9 others. Blut, 1988. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha. Papers, record 3277680. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3277680
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Busulfan | Major topic |
| Hydroxyurea | Major topic |
| Interferon Type I | Major topic |
| Leukemia, Myeloid | Major topic |
| Clinical Trials as Topic | |
| Humans | |
| Middle Aged | |
| Random Allocation |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4552811 | Hydroxyurea therapy in chronic myelogenous leukemia. | Cancer | 1972 | https://conductscience.org/library/papers/4552811 | PubMed |
| 2 | 6956430 | Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia. | Cancer | 1982 | https://conductscience.org/library/papers/6956430 | PubMed |
| 3 | 282922 | Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol). | Blood | 1979 | https://conductscience.org/library/papers/282922 | PubMed |
| 4 | 3457264 | Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. | N Engl J Med | 1986 | https://conductscience.org/library/papers/3457264 | PubMed |
| 5 | 13712355 | Busulfan in the treatment of chronic myelocytic leukemia. The effect of long term intermittent therapy. | Blood | 1961 | https://conductscience.org/library/papers/13712355 | PubMed |
| 6 | 7012623 | Chronic myelogenous leukemia--new concepts (first of two parts). | N Engl J Med | 1981 | https://conductscience.org/library/papers/7012623 | PubMed |
| 7 | 6584184 | Prognostic discrimination in "good-risk" chronic granulocytic leukemia. | Blood | 1984 | https://conductscience.org/library/papers/6584184 | PubMed |
| 8 | 87832 | Karyotypic conversion in Ph1-positive chronic myeloid leukaemia with combination chemotherapy. | Lancet | 1979 | https://conductscience.org/library/papers/87832 | PubMed |
| 9 | 3516621 | [alpha 2-interferon: preliminary treatment results in chronic myeloid leukemia]. | Dtsch Med Wochenschr | 1986 | https://conductscience.org/library/papers/3516621 | PubMed |
| 10 | 3526559 | Management of chronic myelogenous leukemia. | Semin Hematol | 1986 | https://conductscience.org/library/papers/3526559 | PubMed |
| 11 | 3864497 | Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival. | Blood | 1985 | https://conductscience.org/library/papers/3864497 | PubMed |
| 12 | 3463397 | Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia. | Cancer | 1986 | https://conductscience.org/library/papers/3463397 | PubMed |
| 13 | 3510388 | Bone marrow transplantation for patients with chronic myeloid leukemia. | N Engl J Med | 1986 | https://conductscience.org/library/papers/3510388 | PubMed |
| 14 | 3855444 | Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia. | J Clin Oncol | 1985 | https://conductscience.org/library/papers/3855444 | PubMed |
| 15 | 3113712 | A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of cancer and leukemia group B. | Cancer | 1987 | https://conductscience.org/library/papers/3113712 | PubMed |
| 16 | 3511810 | Marrow transplantation for the treatment of chronic myelogenous leukemia. | Ann Intern Med | 1986 | https://conductscience.org/library/papers/3511810 | PubMed |
| 17 | 3904870 | Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. | Blood | 1985 | https://conductscience.org/library/papers/3904870 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 2796252 | Budd-Chiari syndrome and thrombosis of other abdominal vessels in the chronic myeloproliferative diseases. | Klin Wochenschr | 1989 | https://conductscience.org/library/papers/2796252 | PubMed |
| 2736308 | A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia. | Blut | 1989 | https://conductscience.org/library/papers/2736308 | PubMed |
| 2644994 | Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2a. | Blut | 1989 | https://conductscience.org/library/papers/2644994 | PubMed |
| 2597774 | Polycythemia vera. A clinical study of 141 patients. | Blut | 1989 | https://conductscience.org/library/papers/2597774 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3277680
GET https://conductscience.org/api/papers/v1/3277680/authors